Personalized Risk Stratification of Residual Histologic Activity in IBD Using Circulating Cytokines
Nikolaos Martinos, Christos Kroupis, Marilena Stamouli, Andreas C. Lazaris, Georgia-Eleni Thomopoulou · 2026
Read Personalized Risk Stratification of Residual Histologic Activity in IBD Using Circulating Cytokines by Nikolaos Martinos, Christos Kroupis, Marilena Stamouli, Andreas C. Lazaris, Georgia-Eleni Thomopoulou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13208867.txt.
Description
Nikolaos Martinos and co-authors tested whether blood markers can spot hidden gut inflammation in bowel disease patients whose gut lining looks healed, in a 2026 study. In ulcerative colitis, the surface can look calm through a scope while tissue samples still show active disease. That hidden activity raises the risk of relapse. The team measured two signaling proteins and one standard inflammation marker in blood taken before a colon exam.
The main group held thirty-one patients whose colitis looked quiet. Nearly half of them still had active tissue disease. One marker, interleukin-10, sorted them best: low levels flagged the hidden activity with good accuracy. A second marker added little alone but refined the risk groups when paired with the first. The combined ladder ran from seven percent active in the lowest group to all active in the highest. The authors call for bigger trials.
Catalog record
| CREATOR | Nikolaos Martinos, Christos Kroupis, Marilena Stamouli, Andreas C. Lazaris, Georgia-Eleni Thomopoulou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |